Abiomed (US) developing laser tissue repair
This article was originally published in Clinica
Abiomed (US) has initiated a study to develop a laser-assisted tissue welding technique as an alternative to conventional suture tying in bladder augmentation procedures. A $100,000 grant from the NIH has been received for the project which will initially test two lasers and determine important factors for optimising the technology in urological applications. The next phase of the study will examine the chronic healing characteristic of the tissue repair.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.